Oxford Textbook of Critical Care

Author:   Andrew R. Webb ,  Marc Shapiro ,  Mervyn Singer ,  Peter Suter
Publisher:   Oxford University Press
ISBN:  

9780192627377


Pages:   1458
Publication Date:   01 October 1998
Format:   Hardback
Availability:   To order   Availability explained
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Our Price $795.00 Quantity:  
Add to Cart

Share |

Oxford Textbook of Critical Care


Add your own review!

Overview

Full Product Details

Author:   Andrew R. Webb ,  Marc Shapiro ,  Mervyn Singer ,  Peter Suter
Publisher:   Oxford University Press
Imprint:   Oxford University Press
Dimensions:   Width: 21.90cm , Height: 7.00cm , Length: 27.60cm
Weight:   4.156kg
ISBN:  

9780192627377


ISBN 10:   0192627376
Pages:   1458
Publication Date:   01 October 1998
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   To order   Availability explained
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Table of Contents

1 RESUSCITATION; 1.1 Respiratory management; 1.1.1 Basic airway management: J.M Field and P.J.F Baskett; 1.1.2 Indications for intubation: R.F Armstrong; 1.1.3 Restoring ventilation: R.F Armstrong; 1.2 Circulatory Management; 1.2.1 Pathophysiology and causes of cardiac arrest: N. Nichol and C. Robertson; 1.2.2 Cardiac massage: S. Sun and M.H Weil; 1.2.3 Therapeutic strategies during cardiac arrest: W.J Moore and P.J.F Baskett; 1.2.4 Resuscitating and protecting the brain: P. Safar and P.M Kochanek; 1.2.5 Post-resuscitation management: W. Tang and M.H Weil; 1.3 Fluid Management; 1.3.1 Physiology of body fluids: P.L Khimenko and A.E Taylor; 1.3.2 Therapeutic strategy for fluid replacement: M.J Shapiro; 1.3.3 Therapeutic goals: W.C Shoemaker; 1.3.4 The fluid challenge: A.R Webb; 2 THE RESPIRATORY SYSTEM; 2.1 Normal Physiology; 2.1.1 The Respiratory System: G. Hedenstierna and H.U Rothen; 2.2 Upper airway obstruction; 2.2.1 Airway control and upper airway obstruction: P.D Cameron and P.V van Heerden; 2.3 The breathless patient; 2.3.1 Control of breathing: H. Burchardi and D.W Richter; 2.3.2 Control of breathing: external influences and abnormalities: H. Burchardi and C.-P.Criee; 2.3.3 Causes of breathlessness: S. Benito; 2.3.4 Therapeutic approach to breathlessness: S. Benito; 2.4 Acute respiratory failure; 2.4.1 Hypoventilation: J. Milic-Emili and T. Similowski; 2.4.2 Pathophysiology of acute respiratory distress syndrome and acute lung injury; 2.4.3 Pulmonary mechanical dysfunction: J. Milic-Emili and T. Similowski; 2.4.4 Cardiovascular interactions: M.R. Pinsky; 2.4.5 Therapeutic strategy: M. Sair and T.W Evans; 2.5 Severe Hypoemia; 2.5.1 Pathophysiology and causes: C.W Hanson and B.E Marshall; 2.5.2 Therapeutic approach: L. Gattinoni and D. Chiumello; 2.6 Aspiration and inhalation; 2.6.1 Aspiration of gastric contents: G.J Bellingan; 2.6.2 Inhalational injury: D.T Harrington and B.A Pruitt Jr; 2.7 Acute bronchospasm; 2.7.1 Pathophysiology and causes: M.-D Schaller and D. Tagan; 2.7.2 Therapeutic approach to bronchospasm and asthma: K.M Nolan and C.S Garrard; 2.8 Acute on chronic airflow limitation; 2.8.1 Pathphysiology: R. Fernandez and A. Artigas; 2.8.2 Therapeutic strategy: P.Jolliet and J.-C Chevrolet; 2.9 Respiratory acidosis; 2.9.1 Pathophysiology and causes: L. Gattinoni and A. Lissoni; 2.9.2 Therapeutic Strategy: L. Gattinoni and A. Lissoni; 2.10 Respiratory alkalosis; 2.10.1 Pathophysiology: J.-C Chevrolet and R. Zurcher Zenklusen; 2.10.2 Causes and therapeutic strategy: J.-C Chevrolet and R. Zucher Zenklusen; 2.11 Failure to wean from mechanical ventilation; 2.11.1 Pathophysiology of respiratory muscle dysfunction: M. Aubier; 2.11.2 Pathophysiology cardiorespiratory interactions: M. R Pinsky; 2.11.3 Increased work of breathing: R. Dhand and M.J Tobin; 2.11.4 Causes of failure to wean: T.E Oh; 2.11.5 Therapeutic approach: T.E Oh; 2.12 Acute pneumonia; 2.12.1 Pathophysiology: J. Rello and A. Torres; 2.12.2 Causes and diagnosis of severe community-acquired pneumonia: J. Dorca and A. Torres; 2.12.3 Causes and diagnosis of nosocomial pneumonia: J. Dorca and A. Torres; 2.12.4 Therapeutic approach: A. Torres and M. El-Ebiary; 2.13 Viral pneumonitis and atypical pneumonia; 2.13.1 Pathophysiology and causes: J.-F Timsit and J. Carlet; 2.13.2 Therapeutic approach: J.-F Timsit and J. Carlet; 2.14 Pneumothorax; 2.14.1 Pathophysiology of pneumothorax: M. Sydow; 2.14.2 Assessment and management: R.C Tilley and B.F Keogh; 2.14.3 Management of bronchial fistulas - pleural, esophageal, and aortic: E.S Kassis and J.D Luketich; 2.15 Pleural effusion; 2.15.1 Pathophysiology of pleural effusion: H.T Billy and K. Waxman; 2.15.2 Indications for drainage of pleural effusion: B.K Evetts and K. Waxman; 2.15.3 Drainage techniques: R. Nirula and K. Waxman; 2.15.4 Management of hemothorax: J.A McGuigan; 2.16 Atelectasis and sputum retention; 2.16.1 Pathophysiology of sputum retention: F. Potie and C. Martin; 2.16.2 Conditioning of inhaled respiratory gases: L. Thomachot and C. Martin; 2.16.3 Therapeutic approach: R. Vialet and C. Martin; 2.17 Hemoptysis; 2.17.1 Pathophysiology and causes: R. Zurcher Zenklusen and P. Jolliet; 2.17.2 Therapeutic approach: R. Zurcher Zenklusen and P. Jolliet; 3 Cardiovascular system; 3.1 Normal Physiology; 3.1.1 The cardiovascular system: B.A Foex and R.A Little; 3.2 Acute chest pain; 3.2.1 Causes and diagnosis of chest pain: J.R McEwan; 3.2.2 Diagnosis and management of angina pectoris: J.R McEwan; 3.3 Acute Myocardial Infarction; 3.3.1 Pathophysiolgy: M.J Davies; 3.3.2 Diagnosis: P. Sleight; 3.3.3 Management: P. Sleight; 3.4 Aortic Dissection; 3.4.1 Pathophysiology: J. Salmon; 3.4.2 Diagnosis: J. Salmon and L.J Jarvis; 3.4.3 Management: J. Salmon; 3.5 The hypotensice patient; 3.5.2 Causes: A. Sielenkamper and W.J Sibbald; 3.5.3 Therapeutic strategy: A Sielenkamper and W.J Sibbald; 3.6 Cardiac failure; 3.6.1 Pathophysiology of myocardial failure and the systemic circulatory response: M. Singer; 3.6.2 Therapeutic strategy: M. Singer; 3.7 Tachyarrhythmias; 3.7.1 Causes and diagnosis: M.C Sayers and C.M Gasperetti; 3.7.2 Therapeutic strategy: M.C Sayers and C.M Gasperetti; 3.8 Bradyarrhythmias; 3.8.1 Causes and diagnosis: C.M Gasperetti and M.C Sayers; 3.8.2 Therapeutic strategy: C.M Gasperetti and M.C Sayers; 3.9 Endocarditis; 3.9.1 Pathophysiology and causes: A.P.R Wilson; 3.9.2 Prevention: A.P.R Wilson; 3.9.3 Treatment: A.P.R Wilson; 3.10 Severe hypertension; 3.10.1 Pathophysiology and causes: E.A Panacek; 3.10.2 Management: E.A Panacek; 3.11 Severe capillary leak; 3.11.1 Pathophysiology: T.M Moore and A.E Taylor; 3.11.2 management of non-cardiogenic pulmonary edema: L. Oppenheimer; 3.12 Pericardial tamponade; 3.12.1 Pathophysiology and causes: W.C Shoemaker; 3.12.2 Management: W.C Shoemaker; 3.13 Pulmonary hypertension; 3.13.1 Pathophysiology and causes: D. Pappert and K.J Falke; 3.13.2 Management: R. Rossaint and K. Falke; 3.14 Pulmonary vascular obstruction; 3.14.1 Capillary occlusion: B. Zwissler and K. Messmer; 3.14.2 Pulmonary embolus: E.P Wilsonand R.A White; 4 The gastrointestinal and hepatic system; 4.1 Normal physiology; 4.1.1 The gastrointenstinal system: U. Haglund; 4.1.2 The hepatic system: S. Beloucif and D.M Payen; 4.2 Gastrointestinal hemorrhage; 4.2.1 Upper gastrointestinal hemorrhage: H.J Dworken; 4.2.2 Variceal bleeding: H.J Dworken; 4.2.3 Lower gastrointestinal hemorrhage: H.J Dworken; 4.3 The acute abdomen; 4.3.1 Perforated viscus: J.W.M Greve and G. Ramsay; 4.3.2 Ischemic bowel: A. Marston; 4.3.3 Intra-abdominal sepsis: H. van Goor and R.J.A Goris; 4.3.4 Acute acalculous cholecystitis: M.J Shapiro; 4.4 Pancreatitis; 4.4.1 Pathophysiology and diagnosis: T. Dugernier and M.S Reynaert; 4.4.2 Conservative management: T. Dugernier and P.J. Kestens; 4.4.3 Surgical management: B. Rau and H.G Beger; 4.5 Disordered gastric motility; 4.5.1 Vomiting: G.J Dobb; 4.5.2 Large nasogastric aspirates: G.J Dobb; 4.5.3 Ileus and obstruction: D.C Evans and J.C Marshall; 4.5.4 Diarrhea: G.J Dobb; 4.5.4 Constipation: G.J Dobb; 4.6 Jaundice; 4.6.1 Pathophysiology and causes: A.E.S Gimson; 4.6.2 Therapeutic strategy: A.E.S Gimson; 4.7 Acute hepatic failure; 4.7.1 Pathophysiology and causes: R. Williams; 4.7.2 Diagnosis and assessment: F. Hawker; 4.7.3 Management: J. Wendon; 4.7.4 Management of complications: F. Hawker; 4.7.5 The effect of acute hepatic failure on drug handling: T.S Leary and G.R Park; 5 Nutrition; 5.1 Normal physiology; 5.1.1 Nutrition: K.N Jeejeebhoy; 5.2 Nutritional failure; 5.2.1 The metabolic and nutritional response to critical illness: G.Lavery; 5.2.2 Pathophysiology of nutritional failure: S.M Gabe and G.K Grimble; 5.2.3 Assessing nutritional status: J.-M Boles; 5.3 Nutritional support; 5.3.1 Enteral nutrition: G.J Dobb; 5.3.2 Parenteral nutrition: G. Iapichino and D. Radrizzani; 6 The Renal system; 6.1 Normal physiology; 6.1.1 The renal system: J. Reichmann and M. Brezis; 6.2 Oliguria; 6.2.1 Diagnosis and assessment: C. Ronco and A.G Fabris; 6.2.2 Management: J.J Cordingley and M.G.A Palazzo; 6.3 Acute renal failure; 6.3.1 Pathophysiology: J. Reichmann and M. Brezis; 6.3.2 Diagnosis: R. Bellomo and C. Ronco; 6.3.3 Management: R. Bellomo and C. Ronco; 6.4 Established renal failure; 6.4.1 The effect of renal failure on drug handling: A. Olyaei and W.M Bennett; 6.4.2 The effect of chronic renal failure on critical illness: R.G Woolfson; 7 The neurological system; 7.1 Normal physiology; 7.1.1 The nervous system: M.W Nicolle and G.B Young; 7.2 The unconscious patient; 7.2.1 Pathophysiolgy: E. Oschatz and A.N Laggner; 7.2.2 Causes and diagnosis: T.P Black and A.R Webb; 7.2.3 Management: T.P Black and A.R Webb; 7.3 Seizures; 7.3.1 Pathophysiolog and causes: T.P Black; 7.3.2 Assessment: T.P Black; 7.3.3 Management: T.P Black; 7.4 Raised intracranial pressure and cerebral edema; 7.4.1 Pathophysiology and generalized cerebral edema: L.F Marshall; 7.4.2 Pathophysiology of space-occupying lesions: E.M Trinidad and T.H Milhorat; 7.4.3 Diagnosis of raised intracranial pressure: A. Mallick and N.M Dearden; 7.4.4 Management of cerebral edema: H. Klein and N.M Dearden; 7.5 Non-traumatic intracranial hemorrhage; 7.5.1 Assessment: H.M Fernandes and A.D Mendelow; 7.5.2 Medical management: M.J.G Harrison; 7.5.3 The role of surgical management: H.M Fernandes and A.D Mendelow; 7.6 Meningitis; 7.6.1 Pathophysiology and causes: M. Levin and S. Nadel; 7.6.2 Therapeutic approach: M. Levin and S. Nadel; 7.7 Encephalitis; 7.7.1 Pathophysiology and causes: R.P Paczynski and D.B Clifford; 7.7.2 Therapeutic approach: R.P Paczynski and D.B Clifford; 7.8 Acute weakness; 7.8.1 Pathophysiology and causes of neuropathy: C.F Bolton; 7.8.2 Pathophysiology and causes of myopathy: C.F Bolton; 7.8.3 Assessment: J. Coakley; 7.8.4 Management: J. Coakley; 7.8.5 Specific treatment for Guillain-Barre syndrome: D. Hunt and D.J Cook; 7.9 Acute myasthenia; 7.9.1 Pathophysiology: L. Loh; 7.9.2 Assessment: L. Loh; 7.9.3 Treatment: L. Loh; 7.9.4 Crisis in myasthenia gravis: L. Loh; 7.10 Tetanus; 7.10.1 Pathophysiology: M. Hopley and J. Lipman; 7.10.2 Prevention and management: H. Hon and J. Lipman; 7.11 Brainstem death and management of the potential; 7.11.1 The diagnosis of brainstem death: C.J Hinds; 7.11.2 Managing the potential organ donor: C.J Hinds; 7.11.3 Management of the relatives of a potential organ donor: B. Watson and V. Morgan; 7.11.4 The organ donation process: I.J.A Davidson and D.A Payne; 7.12 Sleep disturbance; 7.12.1 Pathophysiology: N.P Hirsch and R.S Howard; 7.12.2 Therapeutic strategy: N.P Hirsch and R.S Howard; 7.13 Agitation and confusion; 7.13.1 Causes: S. Heckers and T. Stern; 7.13.2 Therapeutic management: S. Heckers and T. Stern; 7.13.3 Therapeutic management: S. Heckers and T. Stern; 7.14 Pain; 7.14.1 Pathophysiology: M. Schafer and C. Stein; 7.14.2 Assessment: A.R Molloy and M.J Cousins; 7.14.3 Management: A.R Molloy and M.J Cousins; 8 The metabolic and endocrine systems; 8.1 Normal Physiology; 8.1.1 The endocrine system: D. Watson; 8.2 Electrolyte disturbance; 8.2.1 Hypernatremia: A.I Arieff; 8.2.2 Hyponatremia: A.I Arieff; 8.2.3 Hyperkalemia: J. Salmon; 8.2.4 Hypokalemia: J. Salmon; 8.2.5 Hypomagnesemia: H.G Wakeling and M.G Mythen; 8.2.6 Hypercalcemia: N.B Eastwood and M.G Mythen; 8.2.7 Hypocalcemia: T.J Gan; 8.2.8 Hyperphosphatemia: J.V Booth and M.G Mythen; 8.2.9 Hypophosphatemia: J.V Booth and M.G Mythen; 8.3 Metabolic acidosis; 8.3.1 Pathophysiology and causes: D.M Forrest and J.A Russell; 8.3.2 Therapeutic strategy: D.M Forrest and J.A Russell; 8.4 Metabolic alkalosis; 8.5 Hyperglycemia; 8.5.1 Pathophysiology: G. Bishop and K. Hillman; 8.5.2 Assessment: G. Bishop and K. Hillman; 8.5.3 Management of hyperglycemia: P. Bristow and K. Hillman; 8.5.4 Management of hyperglycemic diabetic emergencies: P. Bristow and K. Hillman; 8.6 Hypoglycemia; 8.6.1 Pathophysiology: R.B Noone and M.G Mythen; 8.6.2 Therapeutic strategy: I.C Sanderson and M.G Mythen; 8.7 Hypoadrenalism; 8.7.1 Pathophysiology: L.G Thijs; 8.7.2 Therapeutic strategy: L.G Thijs; 8.8 Hypopituitarism; 8.8.1 Pathophysiology: G. Van den Berghe; 8.8.2 Therapeutic strategy: G. Van den Berghe; 8.9 Hyperthyroidism; 8.9.1 Pathophysiology: D. Watson; 8.9.2 Therapeutic strategy: D. Watson; 8.10 Hypothyroidism; 8.10.1 Pathophysiology: S. Arlot and A. Fournier; 8.10.2 Therapeutic strategy: S. Arlot and A. Fournier; 9 Poisoning; 9.1 Principles of management; 9.1.1 Role of toxicology assessment: A. Jaeger; 9.1.2 Elimination techniques: S.W Borron and C. Bismuth; 9.2 Management of specific poisons; 9.2.1 Salicylate: J.A Henry; 9.2.2 Acetaminophen (paracetamol): A. Rhodes and J. Wendon; 9.2.3 Opiates: G. Conti and A. Gasparetto; 9.2.4 Benzodiazepines: P. Lheureux and M. Vranckx; 9.2.5 Tricyclic antidepressants: J.A Henry and M.C Colbridge; 9.2.6 Amphetamines and ecstasy: T.K Hartung and J.A Henry; 9.2.7 Digoxin: E.M Antman and T.W Smith; 9.2.8 Cocaine: M.E Palmer and L.R Goldfrank; 9.2.9 Beta-Blockers: S.W Metcalf; 9.2.10 Cyanide: D.G Penney and W.E Porter; 9.2.11 Alcohols: D. Jacobsen; 9.2.12 Carbon monoxide: S.G Simonson and C.A Piantadosi; 9.2.13 Corrosives: S.W Metcalf; 9.2.14 Pesticides and agricultural chemicals: K. Koyama; 10 The haematological system; 10.1 Normal physiology; 10.1.1 The blood cells: K.K Hampton and C.A.J Wardrop; 10.2 Disordered coagulation; 10.2.1 Pathophysiology: A.C Nathwani and S.J Machin; 10.2.2 Disseminated intravascular coagulation: D. Cummins; 10.2.3 Thrombosis: H. Cohen and C. Ozanne; 10.2.4 Thrombocytopenia: C.N Harrison and S.J Machin; 10.3 The neutropenic patient; 10.3.1 Pathophysiology: A.C Nathwani and A.H Goldstone; 10.3.2 Management of neutropenia and its consequences: A.C Nathwani and A.H Goldstone; 10.4 Anemia; 10.4.1 Pathophysiology: E.C.M van Gorp and H. ten Cate; 10.4.2 Hemolysis: J.P Isbister; 10.4.3 Blood transfusion: P. Hewitt and F. Regan; 10.5 Polycythemia; 10.5.1 Pathophysiology: C.A.J Wardrop; 10.5.2 Therapeutic strategy: C.A.J Wardrop; 10.6 Sickle crisis; 10.6.1 Pathophysiology: G.R Serjeant; 10.6.2 Prevention and management of complications: G.R Serjeant and M. Singer; 11 Trauma, burns and physical disorders; 11.1 Multiple trauma; 11.1.1 Pathophysiology of chest trauma: P.A Carli and M. Lejay; 11.1.2 Pathophysiology of abdominal trauma: J. Biert and R.J.A Goris; 11.1.3 Assessment: R.F Wilson and J.G Tyburski; 11.1.4 Management of the chest injury: J.E Mazuski and R.M Durham; 11.1.5 Management of abdominal injury: M. Poeze and G. Ramsay; 11.1.6 Rhabdomyolysis and compartment syndrome: J.-M Boles; 11.1.7 Fat embolism: J.M Ryan and S.W Metcalf; 11.1.8 Air embolis: C. O'Donnell and M. Gavalas; 11.1.9 The role of surgical managment of fractures: R.J.A Goris and J. Biert; 11.2 Ballistic trauma; 11.2.1 Pathophysiology: D.V Shatz and O.C Kirton; 11.2.2 Assessment: K.A Kralovich and H.M Horst; 11.2.3 Management: R.C Karmy-Jones and J.W Wagner; 11.3 Head injury; 11.3.1 Pathophysiology: J. Jallo and R.K Narayan; 11.3.2 Assessment: J. Jallo and R.K Narayan; 11.3.3 Medical Management: A. Main and N.M Dearden; 11.3.4 The role of surgery: R.P Boyer and J.J Oro; 11.4 Spinal injury; 11.4.1 Pathophysiology: C. Werner; 11.4.2 Management of cervical cord injury: C. Werner; 11.4.3 Management of spinal cord injury: R.S.R Fox; 11.5 Burns; 11.5.1 Pathophysiology: J. Hammond; 11.5.2 Assessment: J.B Cone and R.D Robertson; 11.5.3 Medical Management: J.B Cone and R.D Robertson; 11.5.4 Role of Surgical Management: J.R Saffle; 11.6 Drowning; 11.6.1 Pathophysiology: P.G Boysen and J.E Szalados; 11.6.2 Management: P.G Boysen and J.E Szalados; 11.7 Electrocution; 11.7.1 Pathophysiology: R.F Armstrong; 11.7.2 Management: R.F Armstrong; 11.8 Noise; 11.8.1 Pathophysiology: D. Balogh and A. Benzer; 11.8.2 Management: D. Balogh and A. Benzer; 11.9 Altitude- and depth-related critical illness; 11.9.1 Pathophysiology related to altitude: W. Schobersberger and N. Mutz; 11.9.2 Pathophysiology related to depth: W. Hasibeder and N. Mutz; 11.9.3 Management: M. Maggiorini; 11.10 Hyperthermia and pyrexia; 11.10.1 Pathophysiology of fever: D.C Macallan; 11.10.2 Assessment of fever: D.C Macallan; 11.10.3 Management of fever: D.C Macallan; 11.10.4 Pathophysiology of malignant hyperthermia: P.J Halsall and F.R Ellis; 11.10.5 Management of malignant hyperthermia: P.J Halsall and F.R Ellis; 11.10.6 Pathophysiology of heat-stroke: A.M.S Kashmeery; 11.10.7 Management of heat-stroke: C.J Ash and A.M.S Kashmeery; 11.11 Hypothermia; 11.11.1 Pathophysiology: M.-D Schaller and P. Eckert; 11.11.2 Management: M.-D Schaller and P. Eckert; 11.12 Transport of the critically ill patient; 11.12.1 Pathophysiology related to movement of the critically ill: B.J Tortella and M.J Shapiro; 11.12.2 Minimizing risk during transport: J.E Gilligan; 11.12.3 Equipment required for in-hospital transfer: S.A Ridley; 11.12.4 Equipment required for between-hospital transfer: A.G Morrison and P.G.M Wallace; 11.12.5 Personnel required for transport: A. Bristow and M.J Shapiro; 12 Obstetric problems; 12.1 Normal physiology; 12.1.1 Obstetrics: C. Nelson-Piercy and M. de Swiet; 12.2 Pre-eclampsia and eclampsia; 12.2.1 Pathophysiology: D.O.C Anumba and S.C Robson; 12.2.2 Management of pre-eclampsia: D.O.C Anumba and S.C Robson; 12.2.3 Management of eclampsia: S.C Robson; 12.3 HELLPsyndrome; 12.3.1 Pathophysiology: P.F Laterre and M.S Reynaert; 12.3.2 Therapeutic strategy: P.F Laterre and T. Dugernier; 12.4 Postpartum hemorrhage; 12.4.1 Pathophysiology and therapeutic strategy: H. El-Refaey and J. Kingdom; 12.5 Obstetric emboli; 12.5.1 Pathphysiology: T. Dugernier and M.S Reynaert; 12.5.2 Therapeutic strategy: T. Dugernier and P.F Laterre; 13 Infection and systemic inflammation; 13.1 Normal physiology; 13.1.1 Immunology: P.G Medd and B.M Chain; 13.2 Infection and control issues; 13.2.1 Hygiene: G.L Ridgway; 13.2.2 Isolation: G.L Ridgway; 13.2.3 Antimicrobial selection policies: A.P.R Wilson; 13.2.4 Selective decontamination: C.P Stoutenbeek and H.K.F van Saene; 13.3 Nosocomial infection; 13.3.1 Pathophysiology and management: P.S Barie and J.T Cooke; 13.3.2 Prevention: S. Harbarth and D. Pittet; 13.4 Infection in the immunocompromised; 13.4.1 Drug-induced depression of immunity: M. Chapman and S. Peake; 13.4.2 Immune dysfunction associated with critical illness: G.J Bellingan; 13.5 HIV-related disease; 13.5.1 Infections associated with HIV: M.G Brook and R.F Miller; 13.5.2 Role of intensive care in HIV disease: R.F Miller and M.G Brook; 13.6 Tropical diseases; 13.6.1 Malaria: C.J.M Whitty and P.L Chiodini; 13.6.2 Other tropical diseases: C.J.M Whitty and P.L Chiodini; 13.7 Multisystem involvement in shock; 13.7.1 Assessment: O. Boyd and P. Newman; 13.7.2 Therapeutic strategy: P. Newman and R.M Grounds; 13.8 Multiple organ failure; 13.8.1 Pathophysiology: J.F Bion; 13.8.2 Assessment: J.-L Vincent; 13.8.3 Therapeutic strategy: J.-L Vincent; 13.9 Anaphylaxis; 13.9.1 Pathophysiology: J.H Levy and M. Fisher; 13.9.2 Assessment and therapeutic strategy: M. Fisher; 13.10 Connective tissue disorder; 13.10.1 Systemic lupus erythematosus: U.B.S Prakash; 13.10.2 Vasculitis: U.B.S Prakash; 13.10.3 Rheumatoid arthritis: U.B.S Prakash; 14 Perioperative problems; 14.1 General postoperative intensive care; 14.1.1 Recovery from anaesthesia: D.R Miller and A.D Baxter; 14.1.2 Postoperative pain relief: A.D Baxter and D.R Miller; 14.1.3 Ventilatory function in the postoperative period: J.T Cooke and P.S Barie; 14.1.4 Postoperative fluid and circulatory management: R.M Grounds and O. Boyd; 14.2 Management of specilized surgical patients; 14.2.1 Orthopaedic surgery: M. Fennelly and G. Edge; 14.2.2 Vascular surgery: E.P Wilson and R.A White; 14.2.3 Thoracic surgery: J.A McGuigan and K. Lowry; 14.3 Postcardiac surgical intensive care; 14.4 Postneurosurgical intensive care; 14.4.1 Postoperative protection against cerebral injury: M. Smith; 14.4.2 Circulatory management: D.K Menon and A. Swami; 14.4.3 Ventilatory management: M. Smith; 14.5 Post-transplantation surgery; 14.5.1 Renal transplantation: I.J.A Davidson and M. Ulrich; 14.5.2 Cardiac transplantation: G.D Matrich and B.P Griffith; 14.5.3 Hepatic transplantation: M. Manji and J.F Bion; 14.5.4 Lung transplantation: R. Ruggiero and C.A Keller; 15 Management of the critical care department; 15.1 The intensive care department; 15.1.1 Design of the department: T.E Oh; 15.1.2 Site, size and interactions with other departments: D.C Jerwood and E. Major; 15.1.3 Staffing of the department: D. Reis Miranda and L.J. Broerse; 15.1.4 Patient safety: S.J.Y Bard and G.R Park; 15.1.5 Staff safety: P.J Cole and G.R Park; 15.1.6 Staff welfare: P.J Cole and G.R Park; 15.1.7 Fire and electrical safety: J.E Risdall and G.R Park; 15.1.8 The role of intensive care unit policies: B. Morgan and W.J Sibbald; 15.1.9 Resource management: M. Jegers and D. Reis Miranda; 15.2 Medicolegal and ethical issues; 15.2.1 Consent/assent to treatment: S.A.M McLean; 15.2.2 Medical research: S.L Cohen; 15.2.3 Withdrawing treatment: R. Ritz and G. Stratenwerth; 15.2.4 Law enforcement issues: C.P.H Heneghan; 15.2.5 The role of the coroner in the United Kingdom: M.A Branthwaite; 15.2.6 Key differences between the role of the coroner in the United States and the United Kingdom: M. Graham; 15.2.7 Clinical liability: C.P.H Heneghan; 15.3 Scoring systems in intensive care; 15.3.1 The role and limitations of scoring systems: K. Rowan; 15.3.2 Principles of severity scoring: K. Rowan; 15.3.3 Acute Physiolohy and Chronic Health Evaluation (APACHE): J.E Zimmerman and W.A Knaus; 15.3.4 Simplified Acute Physiology Score (SAPS): J.-R Le Gall; 15.3.5 Therapeutic Intervention Scoring System (TISS): D.J Cullen; 15.3.6 Mortality Probability Model (MPM): A.D Collins and S. Lemeshow; 15.3.7 Trauma scoring: H.R Champion and W.J Sacco; 15.3.8 Glasgow Coma Scale: J.E Zimmerman and W.E Knaus; 15.3.9 Sedation scoring: A. Hole and P. Klepstad; 15.3.10 Organ failure scoring: J.C Marshall; 16 Monitoring equipment and techniques; 16.1 Cardiorespiratory monitoring; 16.1.1 ECG monitoring: W.R Lewis and E.S Kaufman; 16.1.2 Pulse oximetry: J.A Pologe; 16.1.3 Blood pressure monitoring: R.M. Gardner; 16.1.4 Central venous catheterization: J.L Peters and R. Moore; 16.1.5 Pulmonary artery catheterization: A.B.J Groeneveld; 16.1.6 Mixed venous saturation monitoring: D. Rosser; 16.1.7 Cardiac output assessment: H.E Montgomery and M. Singer; 16.1.8 Oxygen transport: J.D Edwards; 16.1.9 Right ventricular function: H.E Montgomery; 16.1.10 Measurement of extravascular lung water: P. Frost and D. Bihari; 16.1.11 Gastrointestinal tonometry: G. Gutierrez; 16.2 Blood gases; 16.2.1 Blood gas analyzers: B.A Shapiro; 16.2.2 Blood gas analysis: B.A Shapiro; 16.3 Ventilatory monitoring; 16.3.1 Capnography: L. Blanch and A. Artigas; 16.3.2 Flow-volume and pressure-volume loops: J.C Goldstone; 16.3.3 Monitoring gas exchange and ventilation-perfusion matching: R. Rodriguez-Roisin and J. Roca; 16.3.4 Respiratory muscle function: M. Aubier; 16.3.5 Respiratory system compliance and resistance: J.C Goldstone; 16.4 Imaging; 16.4.1 Imaging the respiratory system: J.A Worrell; 16.4.2 Imaging the cardiovascular system: G. Porenta and G. Maurer; 16.4.3 Doppler echocardiography in intensive care: J.L Fellahi and F. Jardin; 16.4.4 Imaging the upper urinary tract: U. Patel and M.J Kellett; 16.4.5 Imaging the central nervous system: J.M Stevens and C. Mandel; 16.5 Laboratory monitoring; 16.5.1 Biochemical monitoring: D.C Borgstrom and J.A Weigelt; 16.5.2 Lactate: J.-L Vincent; 16.5.3 Colloid osmotic pressure: A.R Webb; 16.5.4 Hematological blood count: I. Cavill and C.A.J Wardrop; 16.5.5 Coagulation monitoring: E.C.M van Gorp and H. ten Cate; 16.5.6 Microbiological monitoring: M.R Jacobs; 16.5.7 Suptum sampling and bronchoalveolar lavage: G.J Bellingan; 16.6 Neurological monitoring; 16.6.1 Electroencephalogram monitoring: N.J Smith; 16.6.2 Intracranial pressure monitoring: R.S Graham and J.D Ward; 16.6.3 Jugular venous bulb monitoring: K. Ahmed and N.M Dearden; 16.6.4 Cerebral blood flow monitoring: P.J.D Andrews and W. Fitch; 16.7 Nutritional monitoring; 16.7.1 Indirect calorimetry: P.G Gauger and R.H Bartlett; 16.8 Specific organ function; 16.8.1 Hepatic function: A. Rhodes and J. Wendon; 16.8.2 Renal function: P.M.J.M de Vries; 17 Pharmaco-therapeutics; 17.1 Drugs in critical illness; 17.1.1 Analgesics: M. Tryba; 17.1.2 Antiarrhythmics: A.K.B Slade and A.J Camm; 17.1.3 Anticoagulants: A.R Webb; 17.1.4 Antidepressants: S. Heckers and T. Stern; 17.1.5 Antidiarrheals; G.J Dobb; 17.1.6 Antiseizure agents: T.P Black; 17.1.7 Antifibrinolytics: S.J Machin; 17.1.8 Antimicrobials: A.P.R Wilson; 17.1.9 Antispasmodics, antiemetics, and drugs enhancing motility: J.J Cordingley and M.G.A Palazzo; 17.1.10 Antithrombotic agents: J.P Isbister; 17.1.11 Aprotinin: A.R Webb; 17.1.12 Blood product therapy: R. Leisner; 17.1.13 Blood substitutes: O.P Habler and K. Messmer; 17.1.14 Bronchodilators: S.W Benham and C.S Garrard; 17.1.15 Diuretics: J.-A Romand; 17.1.16 Fluids: A.R Webb; 17.1.17 Immunotherapy: S. Peake and M.M Fisher; 17.1.18 Inhalational anesthetic agents: E.M Spencer and S.M Willatts; 17.1.19 Inotropic agents: R.N Sladen; 17.1.20 Muscle relaxants: B.J Pollard; 17.1.21 Nitric oxide: A. Mebazaa and D.M Payen; 17.1.22 Oxygen: R.M Jackson; 17.1.23 Prostanoids: A. Brinkmann and P.L Radermacher; 17.1.24 Respiratory stimulants: A.A Jeffrey; 17.1.25 Sedatives: W. Strobel and R. Ritz; 17.1.26 Stress ulcer prophylaxis and antiulcer drugs: D.J Cook; 17.1.27 Surfactant: W. Seeger and A. Gunther; 17.1.28 Vasoconstrictors: J.-A Vincent; 17.1.29 Vasodilator: A.B.J Groeneveld; 18 Therapeutic equipment and techniques; 18.1 Airway access; 18.1.1 Physiology of the intubated airway: G. Hedenstierna; 18.1.2 Preparing the patient for endotracheal intubation: R. Whitta; 18.1.3 Selection of tube and route: R. Whitta; 18.1.4 Techniques of tracheal intubation: R. Whitta; 18.1.5 The difficult intubation: M.E Faymonville and M.Lamy; 18.1.6 Minitracheostomy: D.W Ryan; 18.1.7 Tracheostomy: P.B Hazard; 18.2 Ventilatory support; 18.2.1 Physiology of positive-pressure ventilation: J.C Goldstone; 18.2.2 Continuous positive airways pressure: J.-A Romand and P.M Suter; 18.2.3 Non-invasive positive-pressure ventilation: G.U Meduri; 18.2.4 Indications for mechanical ventilation: R.F Armstrong; 18.2.5 Design and function of mechanical ventilators: R.A Smith; 18.2.6 Respiratory rate: G.J Wrathall; 18.2.7 Tidal and minute volume: G.J Wrathall; 18.2.8 Inspiratory time: G.J Wrathall; 18.2.9 Positive end-expiratory pressure: P.M Suter; 18.2.10 Volume-controlled mechanical ventilation: J.J Marini; 18.2.11 Pressure-controlled mechanical ventilation: S.E Lapinsky and A.S Slutsky; 18.2.12 Pressure support ventilation: J. Mancebo and L. Brochard; 18.2.13 Effects of mechanical ventilation on the circulation: M.R Pinsky; 18.2.14 Effects of mechanical ventilation on other organ function: M. Hemmer; 18.2.15 Ventilator trauma: J.J Marini; 18.2.16 High-frequency ventilation: B.F Keogh and E.H Gluck; 18.2.17 External high-frequency oscillation: M. Nevin; 18.2.18 Other novel modes of ventilation: J. Mancebo and V.M Ranieri; 18.3 Extracorporeal and non-ventilatory support; 18.3.1 Physiology of failure of mechanical ventilation to support gas exchange: K.P Kelly and R. Rossaint; 18.3.2 Extracorporeal respiratory support: L. Gattinoni and L. Brazzi; 18.4 Cardiovascular system; 18.4.1 Defibrillation: R.F Armstrong and G.Maughan; 18.4.2 Pacing and the intensive care unit: H.E Montgomery; 18.4.3 Intra-aortic balloon counterpulsation: P. Kallis; 18.4.4 Sengstaken tube: J. Wendon; 18.5 Renal replacement therapy; 18.5.1 Continuous hemofiltration techniques: M. Schetz; 18.5.2 Hemodialysis: M. Schetz; 18.5.3 Peritoneal dialysis: F.D Thompson; 18.5.4 Plasmapheresis: L.Y Vitou and M. Sternbach

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List